There were 522 press releases posted in the last 24 hours and 166,635 in the last 365 days.

Global Psoriasis Drugs Industry

Psoriasis Drugs market worldwide is projected to grow by US$10. 8 Billion, driven by a compounded growth of 9%. Tumor Necrosis Factor Inhibitor, one of the segments analyzed and sized in this study, displays the potential to grow at over 9%.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Psoriasis Drugs Industry" - https://www.reportlinker.com/p05818016/?utm_source=GNW
The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$8.1 Billion by the year 2025, Tumor Necrosis Factor Inhibitor will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 7.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$367.7 Million to the region’s size and clout in the next 5 to 6 years. Over US$321.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Tumor Necrosis Factor Inhibitor will reach a market size of US$377.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.2% over the next couple of years and add approximately US$3.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AbbVie, Inc.; Amgen, Inc.; Celgene Corporation; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; UCB SA


Read the full report: https://www.reportlinker.com/p05818016/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Psoriasis Drugs Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Psoriasis Drugs Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2018-2025
Table 2: Psoriasis Drugs Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Psoriasis Drugs Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
World Market by Region/Country in US$ Million: 2018 to 2025
Table 5: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
Historic Market Analysis by Region/Country in US$ Million: 2009
to 2017
Table 6: Tumor Necrosis Factor Inhibitor (Therapeutic Class)
Market Share Breakdown of Worldwide Sales by Region/Country:
2009 VS 2019 VS 2025
Table 7: Interleukin Inhibitors (Therapeutic Class) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Interleukin Inhibitors (Therapeutic Class) Historic
Market Perspective by Region/Country in US$ Million: 2009 to
2017
Table 9: Interleukin Inhibitors (Therapeutic Class) Market
Sales Breakdown by Region/Country in Percentage: 2009 VS 2019
VS 2025
Table 10: Other Therapeutic Classes (Therapeutic Class)
Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Other Therapeutic Classes (Therapeutic Class) Region
Wise Breakdown of Global Historic Demand in US$ Million: 2009
to 2017
Table 12: Other Therapeutic Classes (Therapeutic Class) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025
Table 13: Topicals (Treatment) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Topicals (Treatment) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Topicals (Treatment) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Systemic (Treatment) World Market by Region/Country
in US$ Million: 2018 to 2025
Table 17: Systemic (Treatment) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 18: Systemic (Treatment) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Biologics (Treatment) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Biologics (Treatment) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Biologics (Treatment) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Psoriasis Drugs Market Share (in %) by Company: 2019 & 2025
Table 22: United States Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 23: Psoriasis Drugs Market in the United States by
Therapeutic Class: A Historic Review in US$ Million for
2009-2017
Table 24: United States Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 25: United States Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 26: Psoriasis Drugs Market in the United States by
Treatment: A Historic Review in US$ Million for 2009-2017
Table 27: United States Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
CANADA
Table 28: Canadian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 29: Canadian Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 30: Psoriasis Drugs Market in Canada: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 31: Canadian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 32: Canadian Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 33: Psoriasis Drugs Market in Canada: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
JAPAN
Table 34: Japanese Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 35: Psoriasis Drugs Market in Japan: Historic Sales
Analysis in US$ Million by Therapeutic Class for the Period
2009-2017
Table 36: Japanese Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 37: Japanese Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Treatment for the
Period 2018-2025
Table 38: Psoriasis Drugs Market in Japan: Historic Sales
Analysis in US$ Million by Treatment for the Period 2009-2017
Table 39: Japanese Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
CHINA
Table 40: Chinese Psoriasis Drugs Market Growth Prospects in
US$ Million by Therapeutic Class for the Period 2018-2025
Table 41: Psoriasis Drugs Historic Market Analysis in China in
US$ Million by Therapeutic Class: 2009-2017
Table 42: Chinese Psoriasis Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 43: Chinese Psoriasis Drugs Market Growth Prospects in
US$ Million by Treatment for the Period 2018-2025
Table 44: Psoriasis Drugs Historic Market Analysis in China in
US$ Million by Treatment: 2009-2017
Table 45: Chinese Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Psoriasis Drugs Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 46: European Psoriasis Drugs Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 47: Psoriasis Drugs Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 48: European Psoriasis Drugs Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 49: European Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 50: Psoriasis Drugs Market in Europe in US$ Million by
Therapeutic Class: A Historic Review for the Period 2009-2017
Table 51: European Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 52: European Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 53: Psoriasis Drugs Market in Europe in US$ Million by
Treatment: A Historic Review for the Period 2009-2017
Table 54: European Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
FRANCE
Table 55: Psoriasis Drugs Market in France by Therapeutic
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 56: French Psoriasis Drugs Historic Market Scenario in
US$ Million by Therapeutic Class: 2009-2017
Table 57: French Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 58: Psoriasis Drugs Market in France by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 59: French Psoriasis Drugs Historic Market Scenario in
US$ Million by Treatment: 2009-2017
Table 60: French Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
GERMANY
Table 61: Psoriasis Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 62: German Psoriasis Drugs Historic Market Analysis in
US$ Million by Therapeutic Class: 2009-2017
Table 63: German Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 64: Psoriasis Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 65: German Psoriasis Drugs Historic Market Analysis in
US$ Million by Treatment: 2009-2017
Table 66: German Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
ITALY
Table 67: Italian Psoriasis Drugs Market Growth Prospects in
US$ Million by Therapeutic Class for the Period 2018-2025
Table 68: Psoriasis Drugs Historic Market Analysis in Italy in
US$ Million by Therapeutic Class: 2009-2017
Table 69: Italian Psoriasis Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Italian Psoriasis Drugs Market Growth Prospects in
US$ Million by Treatment for the Period 2018-2025
Table 71: Psoriasis Drugs Historic Market Analysis in Italy in
US$ Million by Treatment: 2009-2017
Table 72: Italian Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 73: United Kingdom Market for Psoriasis Drugs: Annual
Sales Estimates and Projections in US$ Million by Therapeutic
Class for the Period 2018-2025
Table 74: Psoriasis Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Therapeutic Class for
the Period 2009-2017
Table 75: United Kingdom Psoriasis Drugs Market Share Analysis
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 76: United Kingdom Market for Psoriasis Drugs: Annual
Sales Estimates and Projections in US$ Million by Treatment for
the Period 2018-2025
Table 77: Psoriasis Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Treatment for the
Period 2009-2017
Table 78: United Kingdom Psoriasis Drugs Market Share Analysis
by Treatment: 2009 VS 2019 VS 2025
SPAIN
Table 79: Spanish Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 80: Spanish Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 81: Psoriasis Drugs Market in Spain: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 82: Spanish Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 83: Spanish Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 84: Psoriasis Drugs Market in Spain: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
RUSSIA
Table 85: Russian Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 86: Psoriasis Drugs Market in Russia by Therapeutic
Class: A Historic Review in US$ Million for 2009-2017
Table 87: Russian Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 88: Russian Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 89: Psoriasis Drugs Market in Russia by Treatment: A
Historic Review in US$ Million for 2009-2017
Table 90: Russian Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 91: Rest of Europe Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 92: Psoriasis Drugs Market in Rest of Europe in US$
Million by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 93: Rest of Europe Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 94: Rest of Europe Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 95: Psoriasis Drugs Market in Rest of Europe in US$
Million by Treatment: A Historic Review for the Period
2009-2017
Table 96: Rest of Europe Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 97: Asia-Pacific Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 98: Psoriasis Drugs Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 99: Asia-Pacific Psoriasis Drugs Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 100: Psoriasis Drugs Market in Asia-Pacific by
Therapeutic Class: Estimates and Projections in US$ Million for
the Period 2018-2025
Table 101: Asia-Pacific Psoriasis Drugs Historic Market
Scenario in US$ Million by Therapeutic Class: 2009-2017
Table 102: Asia-Pacific Psoriasis Drugs Market Share Analysis
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 103: Psoriasis Drugs Market in Asia-Pacific by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 104: Asia-Pacific Psoriasis Drugs Historic Market
Scenario in US$ Million by Treatment: 2009-2017
Table 105: Asia-Pacific Psoriasis Drugs Market Share Analysis
by Treatment: 2009 VS 2019 VS 2025
AUSTRALIA
Table 106: Psoriasis Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 107: Australian Psoriasis Drugs Historic Market Analysis
in US$ Million by Therapeutic Class: 2009-2017
Table 108: Australian Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 109: Psoriasis Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 110: Australian Psoriasis Drugs Historic Market Analysis
in US$ Million by Treatment: 2009-2017
Table 111: Australian Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
INDIA
Table 112: Indian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 113: Indian Psoriasis Drugs Historic Market Review by
Therapeutic Class in US$ Million: 2009-2017
Table 114: Psoriasis Drugs Market in India: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 115: Indian Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 116: Indian Psoriasis Drugs Historic Market Review by
Treatment in US$ Million: 2009-2017
Table 117: Psoriasis Drugs Market in India: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
SOUTH KOREA
Table 118: Psoriasis Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 119: South Korean Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 120: Psoriasis Drugs Market Share Distribution in South
Korea by Therapeutic Class: 2009 VS 2019 VS 2025
Table 121: Psoriasis Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 122: South Korean Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 123: Psoriasis Drugs Market Share Distribution in South
Korea by Treatment: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 124: Rest of Asia-Pacific Market for Psoriasis Drugs:
Annual Sales Estimates and Projections in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 125: Psoriasis Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Therapeutic Class for
the Period 2009-2017
Table 126: Rest of Asia-Pacific Psoriasis Drugs Market Share
Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Table 127: Rest of Asia-Pacific Market for Psoriasis Drugs:
Annual Sales Estimates and Projections in US$ Million by
Treatment for the Period 2018-2025
Table 128: Psoriasis Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Treatment for the
Period 2009-2017
Table 129: Rest of Asia-Pacific Psoriasis Drugs Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 130: Latin American Psoriasis Drugs Market Trends by
Region/Country in US$ Million: 2018-2025
Table 131: Psoriasis Drugs Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 132: Latin American Psoriasis Drugs Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 133: Latin American Psoriasis Drugs Market Growth
Prospects in US$ Million by Therapeutic Class for the Period
2018-2025
Table 134: Psoriasis Drugs Historic Market Analysis in Latin
America in US$ Million by Therapeutic Class: 2009-2017
Table 135: Latin American Psoriasis Drugs Market by
Therapeutic Class: Percentage Breakdown of Sales for 2009,
2019, and 2025
Table 136: Latin American Psoriasis Drugs Market Growth
Prospects in US$ Million by Treatment for the Period 2018-2025
Table 137: Psoriasis Drugs Historic Market Analysis in Latin
America in US$ Million by Treatment: 2009-2017
Table 138: Latin American Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 139: Argentinean Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 140: Psoriasis Drugs Market in Argentina in US$ Million
by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 141: Argentinean Psoriasis Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 142: Argentinean Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 143: Psoriasis Drugs Market in Argentina in US$ Million
by Treatment: A Historic Review for the Period 2009-2017
Table 144: Argentinean Psoriasis Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
BRAZIL
Table 145: Psoriasis Drugs Market in Brazil by Therapeutic
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 146: Brazilian Psoriasis Drugs Historic Market Scenario
in US$ Million by Therapeutic Class: 2009-2017
Table 147: Brazilian Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 148: Psoriasis Drugs Market in Brazil by Treatment:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 149: Brazilian Psoriasis Drugs Historic Market Scenario
in US$ Million by Treatment: 2009-2017
Table 150: Brazilian Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
MEXICO
Table 151: Psoriasis Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 152: Mexican Psoriasis Drugs Historic Market Analysis in
US$ Million by Therapeutic Class: 2009-2017
Table 153: Mexican Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 154: Psoriasis Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Treatment for the
Period 2018-2025
Table 155: Mexican Psoriasis Drugs Historic Market Analysis in
US$ Million by Treatment: 2009-2017
Table 156: Mexican Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 157: Rest of Latin America Psoriasis Drugs Market
Estimates and Projections in US$ Million by Therapeutic Class:
2018 to 2025
Table 158: Psoriasis Drugs Market in Rest of Latin America by
Therapeutic Class: A Historic Review in US$ Million for
2009-2017
Table 159: Rest of Latin America Psoriasis Drugs Market Share
Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Table 160: Rest of Latin America Psoriasis Drugs Market
Estimates and Projections in US$ Million by Treatment: 2018 to
2025
Table 161: Psoriasis Drugs Market in Rest of Latin America by
Treatment: A Historic Review in US$ Million for 2009-2017
Table 162: Rest of Latin America Psoriasis Drugs Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 163: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 164: Psoriasis Drugs Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 165: The Middle East Psoriasis Drugs Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 166: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Table 167: The Middle East Psoriasis Drugs Historic Market by
Therapeutic Class in US$ Million: 2009-2017
Table 168: Psoriasis Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Therapeutic Class for
2009, 2019, and 2025
Table 169: The Middle East Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018 to 2025
Table 170: The Middle East Psoriasis Drugs Historic Market by
Treatment in US$ Million: 2009-2017
Table 171: Psoriasis Drugs Market in the Middle East:
Percentage Share Breakdown of Sales by Treatment for 2009,
2019, and 2025
IRAN
Table 172: Iranian Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Therapeutic Class
for the Period 2018-2025
Table 173: Psoriasis Drugs Market in Iran: Historic Sales
Analysis in US$ Million by Therapeutic Class for the Period
2009-2017
Table 174: Iranian Psoriasis Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 175: Iranian Market for Psoriasis Drugs: Annual Sales
Estimates and Projections in US$ Million by Treatment for the
Period 2018-2025
Table 176: Psoriasis Drugs Market in Iran: Historic Sales
Analysis in US$ Million by Treatment for the Period 2009-2017
Table 177: Iranian Psoriasis Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
ISRAEL
Table 178: Israeli Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Therapeutic Class: 2018-2025
Table 179: Psoriasis Drugs Market in Israel in US$ Million by
Therapeutic Class: A Historic Review for the Period 2009-2017
Table 180: Israeli Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 181: Israeli Psoriasis Drugs Market Estimates and
Forecasts in US$ Million by Treatment: 2018-2025
Table 182: Psoriasis Drugs Market in Israel in US$ Million by
Treatment: A Historic Review for the Period 2009-2017
Table 183: Israeli Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 184: Saudi Arabian Psoriasis Drugs Market Growth
Prospects in US$ Million by Therapeutic Class for the Period
2018-2025
Table 185: Psoriasis Drugs Historic Market Analysis in Saudi
Arabia in US$ Million by Therapeutic Class: 2009-2017
Table 186: Saudi Arabian Psoriasis Drugs Market by Therapeutic
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 187: Saudi Arabian Psoriasis Drugs Market Growth
Prospects in US$ Million by Treatment for the Period 2018-2025
Table 188: Psoriasis Drugs Historic Market Analysis in Saudi
Arabia in US$ Million by Treatment: 2009-2017
Table 189: Saudi Arabian Psoriasis Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 190: Psoriasis Drugs Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 191: United Arab Emirates Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 192: Psoriasis Drugs Market Share Distribution in United
Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
Table 193: Psoriasis Drugs Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Treatment for the Period 2018-2025
Table 194: United Arab Emirates Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 195: Psoriasis Drugs Market Share Distribution in United
Arab Emirates by Treatment: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 196: Psoriasis Drugs Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Therapeutic Class for the Period 2018-2025
Table 197: Rest of Middle East Psoriasis Drugs Historic Market
Analysis in US$ Million by Therapeutic Class: 2009-2017
Table 198: Rest of Middle East Psoriasis Drugs Market Share
Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Table 199: Psoriasis Drugs Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Treatment for the Period 2018-2025
Table 200: Rest of Middle East Psoriasis Drugs Historic Market
Analysis in US$ Million by Treatment: 2009-2017
Table 201: Rest of Middle East Psoriasis Drugs Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
AFRICA
Table 202: African Psoriasis Drugs Market Estimates and
Projections in US$ Million by Therapeutic Class: 2018 to 2025
Table 203: Psoriasis Drugs Market in Africa by Therapeutic
Class: A Historic Review in US$ Million for 2009-2017
Table 204: African Psoriasis Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 205: African Psoriasis Drugs Market Estimates and
Projections in US$ Million by Treatment: 2018 to 2025
Table 206: Psoriasis Drugs Market in Africa by Treatment: A
Historic Review in US$ Million for 2009-2017
Table 207: African Psoriasis Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBVIE
AMGEN
CELGENE CORPORATION
ELI LILLY AND COMPANY
JOHNSON & JOHNSON
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
UCB SA

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818016/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.